Hydrogen sulfide regulates muscle RING finger‐1 protein S‐sulfhydration at Cys44 to prevent cardiac structural damage in diabetic cardiomyopathy. (29th April 2019)
- Record Type:
- Journal Article
- Title:
- Hydrogen sulfide regulates muscle RING finger‐1 protein S‐sulfhydration at Cys44 to prevent cardiac structural damage in diabetic cardiomyopathy. (29th April 2019)
- Main Title:
- Hydrogen sulfide regulates muscle RING finger‐1 protein S‐sulfhydration at Cys44 to prevent cardiac structural damage in diabetic cardiomyopathy
- Authors:
- Sun, Xiaojiao
Zhao, Dechao
Lu, Fangping
Peng, Shuo
Yu, Miao
Liu, Ning
Sun, Yu
Du, Haining
Wang, Bingzhu
Chen, Jian
Dong, Shiyun
Lu, Fanghao
Zhang, Weihua - Abstract:
- Abstract : Background and Purpose: Hydrogen sulfide (H2 S) plays important roles as a gasotransmitter in pathologies. Increased expression of the E3 ubiquitin ligase, muscle RING finger‐1 (MuRF1), may be involved in diabetic cardiomyopathy. Here we have investigated whether and how exogenous H2 S alleviates cardiac muscle degradation through modifications of MuRF1 S‐sulfhydration in db/db mice. Experimental Approach: Neonatal rat cardiomyocytes were treated with high glucose (40 mM), oleate (100 μM), palmitate (400 μM), and NaHS (100 μM) for 72 hr. MuRF1 was silenced with siRNA technology and mutation at Cys 44 . Endoplasmic reticulum stress markers, MuRF1 expression, and ubiquitination level were measured. db/db mice were injected with NaHS (39 μmol·kg −1 ) for 20 weeks. Echocardiography, cardiac ultrastructure, cystathionine‐γ‐lyase, cardiac structure proteins expression, and S‐sulfhydration production were measured. Key Results: H2 S levels and cystathionine‐γ‐lyase protein expression in myocardium were decreased in db/db mice. Exogenous H2 S reversed endoplasmic reticulum stress, including impairment of the function of cardiomyocytes and structural damage in db/db mice. Exogenous H2 S could suppress the levels of myosin heavy chain 6 and myosin light chain 2 ubiquitination in cardiac tissues of db/db mice, and MuRF1 was modified by S‐sulfhydration, following treatment with exogenous H2 S, to reduce the interaction between MuRF1 and myosin heavy chain 6 and myosin lightAbstract : Background and Purpose: Hydrogen sulfide (H2 S) plays important roles as a gasotransmitter in pathologies. Increased expression of the E3 ubiquitin ligase, muscle RING finger‐1 (MuRF1), may be involved in diabetic cardiomyopathy. Here we have investigated whether and how exogenous H2 S alleviates cardiac muscle degradation through modifications of MuRF1 S‐sulfhydration in db/db mice. Experimental Approach: Neonatal rat cardiomyocytes were treated with high glucose (40 mM), oleate (100 μM), palmitate (400 μM), and NaHS (100 μM) for 72 hr. MuRF1 was silenced with siRNA technology and mutation at Cys 44 . Endoplasmic reticulum stress markers, MuRF1 expression, and ubiquitination level were measured. db/db mice were injected with NaHS (39 μmol·kg −1 ) for 20 weeks. Echocardiography, cardiac ultrastructure, cystathionine‐γ‐lyase, cardiac structure proteins expression, and S‐sulfhydration production were measured. Key Results: H2 S levels and cystathionine‐γ‐lyase protein expression in myocardium were decreased in db/db mice. Exogenous H2 S reversed endoplasmic reticulum stress, including impairment of the function of cardiomyocytes and structural damage in db/db mice. Exogenous H2 S could suppress the levels of myosin heavy chain 6 and myosin light chain 2 ubiquitination in cardiac tissues of db/db mice, and MuRF1 was modified by S‐sulfhydration, following treatment with exogenous H2 S, to reduce the interaction between MuRF1 and myosin heavy chain 6 and myosin light chain 2. Conclusions and Implications: Our findings suggest that H2 S regulates MuRF1 S‐sulfhydration at Cys 44 to prevent myocardial degradation in the cardiac tissues of db/db mice. Linked Articles: This article is part of a themed section on Hydrogen Sulfide in Biology & Medicine. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v177.4/issuetoc … (more)
- Is Part Of:
- British journal of pharmacology. Volume 177:Number 4(2020)
- Journal:
- British journal of pharmacology
- Issue:
- Volume 177:Number 4(2020)
- Issue Display:
- Volume 177, Issue 4 (2020)
- Year:
- 2020
- Volume:
- 177
- Issue:
- 4
- Issue Sort Value:
- 2020-0177-0004-0000
- Page Start:
- 836
- Page End:
- 856
- Publication Date:
- 2019-04-29
- Subjects:
- Pharmacology -- Periodicals
Chemotherapy -- Periodicals
Drug Therapy -- Periodicals
Pharmacology -- Periodicals
615.1 - Journal URLs:
- http://bibpurl.oclc.org/web/21844 ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1476-5381/issues ↗
http://www.pubmedcentral.nih.gov/tocrender.fcgi?journal=282&action=archive ↗
http://onlinelibrary.wiley.com/ ↗
http://www.nature.com/bjp/index.html ↗ - DOI:
- 10.1111/bph.14601 ↗
- Languages:
- English
- ISSNs:
- 0007-1188
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 2314.700000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 22197.xml